미국의 투석용 가구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 모달리티 및 용도별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Dialysis Furniture Market Summary

The U.S. dialysis furniture market size was valued at USD 28.34 million in 2024 and is anticipated to reach USD 49.16 million by 2033, expanding at a CAGR of 6.40% from 2025 to 2033. This growth can be attributed to the growing ESRD patient population, expansion of dialysis centers, and increasing adoption of home dialysis setups.

Rising emphasis on patient comfort during long treatment hours, demand for ergonomic and infection-control-focused furniture, and ongoing infrastructure upgrades by large dialysis chains further support market growth. Additionally, technological integration, safety compliance requirements, and replacement cycles for aging equipment continue to drive consistent investment in specialized dialysis furniture across the country. The growing prevalence of chronic kidney disease is a primary driver of the U.S. dialysis furniture market. CKD is a long-term condition in which the kidneys gradually lose their ability to filter waste and excess fluids from the blood, requiring dialysis to sustain health. As CKD cases continue to rise in the U.S., more patients progress to end-stage kidney failure, increasing the need for frequent dialysis treatments and driving demand for specialized dialysis furniture designed for comfort, safety, and long treatment durations. The increasing number of patients is expected to encourage dialysis centers to add more seats and upgrade to modern, comfortable chairs. This is supported by the high number of older adults with CKD, who require chairs that offer better support, easy adjustment features, and greater accessibility.

The figure below shows that CKD has become common in the geriatric population. The data highlights a rise in CKD rates among adults over 60, reflecting age as one of the risk factors for kidney diseases.

The ongoing expansion of dialysis centers across the U.S. is a key driver of the dialysis furniture market, as rising patient volumes are pushing providers to increase treatment capacity and upgrade care environments. New centers and expansions of existing facilities continue to generate strong demand for specialized chairs, tables, cabinets, and supportive furnishings designed for long-duration treatments, patient comfort, and workflow efficiency. According to National ESRD data published in March 2025, the 18 ESRD networks collectively support 7,556 dialysis centers and 223 transplant centers treating more than 516,837 dialysis patients and 316,873 transplant patients nationwide, underscoring the growing need for advanced clinical infrastructure. As providers strive to meet regulatory standards while enhancing patient comfort and efficiency, investments in durable, ergonomic, and high-quality dialysis furniture remain a crucial component of facility development and modernization.

In the U.S. dialysis furniture market, demand for highly customizable equipment is increasing as providers seek solutions tailored to both patient comfort and clinical workflow needs. Because dialysis sessions last three to four hours multiple times per week, facilities prefer chairs and furnishings with adjustable features such as height, recline angle, cushioning, armrest style, and accessory attachments like IV poles, storage trays, reading lights, and touchscreen holders. Providers also value customization that supports diverse room layouts, infection-control protocols, and specialized patient groups, including geriatric, bariatric, and mobility-challenged individuals, through enhanced ergonomic support and higher weight capacities. As clinics continue to expand and modernize, configurable furniture that maximizes patient comfort, accessibility, and operational efficiency is becoming a core purchasing priority across the market.

U.S. Dialysis Furniture Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. dialysis furniture market report on the basis of product, modality/use, andend use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Dialysis Chairs (Recliner)
  • Electric Dialysis Chairs
  • Standard/Manual Dialysis Chairs
• Dialysis Beds
• Task Chairs/Treatment Tables
• Modality/Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hemodialysis
• Peritoneal Dialysis
• Phlebotomy
• Infusion Therapy
• Oncology
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Dialysis Centers (Freestanding Outpatient)
• Home Care Setting (Home Dialysis)
• Hospitals
• Long-Term Care Centers (LTCs) / Skilled Nursing Facilities (SNFs)
• Specialty Clinics
• Ambulatory Surgery Centers (ASCs)

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Modality/Use
  • 1.1.3. End Use
  • 1.1.4. Estimates And Forecast Timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
  • 1.3.5. Details Of Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Price Analysis (Model 1)
  • 1.6.2. Approach 1: Commodity Flow Approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dialysis Furniture Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of kidney diseases
    • 3.2.1.2. Expansion of dialysis centers
    • 3.2.1.3. Increasing shift toward outpatient care
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced dialysis furniture
    • 3.2.2.2. Limited funding and reimbursement
  • 3.2.3. Market Challenge Analysis
    • 3.2.3.1. Workforce shortages in dialysis centers
    • 3.2.3.2. Regulatory complexity
  • 3.2.4. Market Opportunity Analysis
    • 3.2.4.1. Growing preference for customizable furniture
    • 3.2.4.2. Growth of home dialysis
    • 3.2.4.3. Technological advancements
• 3.3. U.S. Dialysis Furniture Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dialysis Furniture Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Dialysis Furniture Market Product Movement Analysis
• 4.3. U.S. Dialysis Furniture Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
• 4.4. Dialysis Chairs
  • 4.4.1. Dialysis Chairs Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.4.2. Electric Dialysis Chairs
    • 4.4.2.1. Electric Dialysis Chairs Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.4.3. Standard/Manual Dialysis Chairs
    • 4.4.3.1. Standard/Manual Dialysis Chairs Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 4.5. Dialysis Beds
  • 4.5.1. Dialysis Beds Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 4.6. Task Chairs/Treatment Tables
  • 4.6.1. Task Chairs/Treatment Tables Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Dialysis Furniture Market: Modality/Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Dialysis Furniture Market Modality/Use Movement Analysis
• 5.3. U.S. Dialysis Furniture Market Size & Trend Analysis, by Modality/Use, 2021 to 2033 (USD Million)
• 5.4. Hemodialysis
  • 5.4.1. Hemodialysis Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 5.5. Peritoneal Dialysis
  • 5.5.1. Peritoneal Dialysis Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 5.6. Phlebotomy
  • 5.6.1. Phlebotomy Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 5.7. Infusion Therapy
  • 5.7.1. Infusion Therapy Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 5.8. Oncology
  • 5.8.1. Oncology Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 6. U.S. Dialysis Furniture Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Dialysis Furniture Market End Use Movement Analysis
• 6.3. U.S. Dialysis Furniture Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
• 6.4. Dialysis Centers (Freestanding Outpatient)
  • 6.4.1. Dialysis Centers (Freestanding Outpatient) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 6.5. Home Care Setting (Home Dialysis)
  • 6.5.1. Home Care Setting (Home Dialysis) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 6.6. Hospitals
  • 6.6.1. Hospitals Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 6.7. Long-Term Care Centers (LTCs) / Skilled Nursing Facilities (SNFs)
  • 6.7.1. Long-Term Care Centers (LTCs) / Skilled Nursing Facilities (SNFs) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 6.8. Specialty Clinics
  • 6.8.1. Specialty Clinics Market Estimates and Forecasts for 2021 to 2033 (USD Million)
• 6.9. Ambulatory Surgery Centers (ASCs)
  • 6.9.1. Ambulatory Surgery Centers (ASCs) Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2024
  • 7.3.2. Champion Manufacturing Inc.
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Usage benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Invacare Corporation
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Usage benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Diasol, Inc.
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Usage benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Digiterm Ltd.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Usage benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Zimed Healthcare LLC
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Usage benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. GF Health Products, Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Usage benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Dynarex Corporation.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Usage benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. SEERS Medical Limited
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Usage benchmarking
    • 7.3.9.4. Strategic initiatives